A multicenter post ‐marketing evaluation of the Elixir DESolve® Novolimus‐eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study

ConclusionsResults through 12 months indicate that the DESolve BRS is a safe and effective treatment for coronary lesions, though larger, long‐term prospective studies are needed.

Source: Catheterization and Cardiovascular Interventions - March 6, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Holger Nef, Jens Wiebe, Niklas Boeder, Oliver D örr, Timm Bauer, Karl‐Eugen Hauptmann, Azeem Latib, Antonio Colombo, Dieter Fischer, Tanja Rudolph, Nicolas Foin, Gert Richardt, Christian Hamm Tags: CORONARY ARTERY DISEASE Source Type: research